In contrast, IRS evaluation of STAT5 showed a significant increase in STAT5 in PCa (mean IRS ± SD: 5.2 ± 2.1) compared to BPH (mean IRS ± SD: 3.9 ± 2.1). This evidence concerns the gene STAT5A and benign prostatic hyperplasia.